Earnings Call · Q3 FY2021·2021-11-08

Q3 21EPS +36.36%·Rev n/aQ2 21EPS -50.00%·Rev n/aQ1 21EPS -100.00%*·Rev n/aQ4 20EPS -100.00%*·Rev n/a⚠ consensus missing

STANDARD BIOTOOLS INC. LAB

Peter Denardo — Executive (likely CFO or similar senior role)

−1.2%1d on move date−1.3% vs SPY3d−4.7%5d+0.8%

Research tier

Behavioral profile computed for this call's speaker on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more LAB calls or request research access.

More LAB calls Browse calls Request research access